Following a satisfactory due diligence investigation, holding company Labat has concluded an agreement with the vendors of Ace Genetics to acquire 100% of the shares in and claims against the Western Cape-based cannabis genetics company for R1.8-million. Effective December 4, the agreement is to be settled through the issue of 1.8-million Labat shares at an issue price of R1 apiece.
from Engineering News | Home https://ift.tt/3n2EES3
